2023 annual financial data
ANI Pharmaceuticals 2023 Operating cash flow growth
Direct answer
Operating cash flow growth was 481.24%.
Operating income was 46,971,000 USD and net income was 18,779,000 USD.
Operating cash flow was 118,959,000 USD.
Get free ANI Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 486,816,000 USD
- Operating income
- 46,971,000 USD
- Net income
- 18,779,000 USD
- Operating cash flow
- 118,959,000 USD